Predominant Α1adrenoceptor-Mediated Contraction in the Human Internal Mammary Artery

GW HE,J SHAW,CF HUGHES,CQ YANG,DS THOMSON,B MCCAUGHAN,PN HENDLE,DK BAIRD
DOI: https://doi.org/10.1097/00005344-199302000-00011
IF: 3.271
1993-01-01
Journal of Cardiovascular Pharmacology
Abstract:Alpha-Adrenoceptor agonists and antagonists are widely used perioperatively for internal mammary artery (IMA)-coronary artery bypass operations. To determine subtypes of alpha-adrenoceptors in the human IMA, we studied responses of isolated human IMA segments to alpha-adrenoceptor agonists, antagonists, and electrical stimulation in organ baths. The IMA ring segments (3 mm long) were set up at a physiologic and comparable condition according to their own length-tension curves. Alpha1-Agonist methoxamine (MO) induced 2.65 +/- 0.70 g force and alpha1, alpha2-agonist norepinephrine (NE) induced 4.07 +/- 0.70 g force. The contractions induced by both MO and NE were totally abolished by al-antagonist prazosin (0.1 muM) but not alpha2-antagonist yohimbine. alpha2-Agonist UK14304 induced only 0.39 +/- 0.17 g force, which was significantly less than that induced by MO or NE (p < 0.001). Contractions induced by electrical field stimulation (2, 10, 20 Hz) were decreased by alpha1-antagonist prazosin 1 muM (p < 0.01) but potentiated by alpha2-antagonist yohimbine. These results strongly suggest that in the human IMA the postjunctional a-adrenoceptors are predominantly of the alpha1-subtype and therefore the alpha-adrenoceptor agonist-induced contraction and the sympathetic nerve stimulation-induced contraction is mediated mainly by activation of the alpha1-adrenoceptors.
What problem does this paper attempt to address?